These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38797183)

  • 1. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design.
    Molina JM; Bercot B; Assoumou L; Rubenstein E; Algarte-Genin M; Pialoux G; Katlama C; Surgers L; Bébéar C; Dupin N; Ouattara M; Slama L; Pavie J; Duvivier C; Loze B; Goldwirt L; Gibowski S; Ollivier M; Ghosn J; Costagliola D;
    Lancet Infect Dis; 2024 Oct; 24(10):1093-1104. PubMed ID: 38797183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
    Molina JM; Charreau I; Chidiac C; Pialoux G; Cua E; Delaugerre C; Capitant C; Rojas-Castro D; Fonsart J; Bercot B; Bébéar C; Cotte L; Robineau O; Raffi F; Charbonneau P; Aslan A; Chas J; Niedbalski L; Spire B; Sagaon-Teyssier L; Carette D; Mestre SL; Doré V; Meyer L;
    Lancet Infect Dis; 2018 Mar; 18(3):308-317. PubMed ID: 29229440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline prophylaxis for the prevention of sexually transmitted infections: A systematic review and meta-analysis of randomized controlled trials.
    Szondy I; Meznerics FA; Lőrincz K; Kemény LV; Walter A; Mohammed AA; Hegyi P; Kiss N; Bánvölgyi A
    Int J Infect Dis; 2024 Oct; 147():107186. PubMed ID: 39122208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
    Luetkemeyer AF; Donnell D; Dombrowski JC; Cohen S; Grabow C; Brown CE; Malinski C; Perkins R; Nasser M; Lopez C; Vittinghoff E; Buchbinder SP; Scott H; Charlebois ED; Havlir DV; Soge OO; Celum C;
    N Engl J Med; 2023 Apr; 388(14):1296-1306. PubMed ID: 37018493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
    Molina JM; Ghosn J; Assoumou L; Delaugerre C; Algarte-Genin M; Pialoux G; Katlama C; Slama L; Liegeon G; Beniguel L; Ohayon M; Mouhim H; Goldwirt L; Spire B; Loze B; Surgers L; Pavie J; Lourenco J; Ben-Mechlia M; Le Mestre S; Rojas-Castro D; Costagliola D;
    Lancet HIV; 2022 Aug; 9(8):e554-e562. PubMed ID: 35772417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.
    Stewart J; Oware K; Donnell D; Violette LR; Odoyo J; Soge OO; Scoville CW; Omollo V; Mogaka FO; Sesay FA; McClelland RS; Spinelli M; Gandhi M; Bukusi EA; Baeten JM;
    N Engl J Med; 2023 Dec; 389(25):2331-2340. PubMed ID: 38118022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial sexually transmitted infections among men who have sex with men and transgender women using oral pre-exposure prophylaxis in Latin America (ImPrEP): a secondary analysis of a prospective, open-label, multicentre study.
    Torres Silva MS; Torres TS; Coutinho C; Ismério Moreira R; da Costa Leite I; Cunha M; da Costa Leite PHA; Cáceres CF; Vega-Ramírez H; Konda KA; Guanira J; Valdez Madruga J; Wagner Cardoso S; Benedetti M; Pimenta MC; Hoagland B; Grinsztejn B; Gonçalves Veloso V;
    Lancet HIV; 2024 Oct; 11(10):e670-e679. PubMed ID: 39243787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men.
    Cornelisse VJ; Riley B; Medland NA
    Med J Aust; 2024 Apr; 220(7):381-386. PubMed ID: 38479437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
    Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A
    Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent chlamydia and gonorrhoea but very infrequent syphilis among men who have sex with men using HIV pre-exposure prophylaxis in West Africa.
    Dah TTE; De Baetselier I; Cuer B; Anoma C; Mensah E; Koné A; Diandé S; Dagnra CA; Faye-Kette HY; Yeo A; Yaya I; Spire B; Keita BD; Crucitti T; Vuylsteke B; Laurent C;
    Sex Transm Infect; 2024 May; 100(4):201-207. PubMed ID: 38604698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial.
    Van Dijck C; Tsoumanis A; Rotsaert A; Vuylsteke B; Van den Bossche D; Paeleman E; De Baetselier I; Brosius I; Laumen J; Buyze J; Wouters K; Lynen L; Van Esbroeck M; Herssens N; Abdellati S; Declercq S; Reyniers T; Van Herrewege Y; Florence E; Kenyon C
    Lancet Infect Dis; 2021 May; 21(5):657-667. PubMed ID: 33676596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline versus azithromycin for the treatment of anorectal Chlamydia trachomatis infection in women concurrent with vaginal infection (CHLAZIDOXY study): a multicentre, open-label, randomised, controlled, superiority trial.
    Peuchant O; Lhomme E; Martinet P; Grob A; Baïta D; Bernier C; Gibaud SA; Le Hen I; Le Naour E; Trignol-Viguier N; Lanotte P; Lefebvre P; Vachée A; Girard T; Loubinoux J; Bébéar C; Ghezzoul B; Roussillon C; Kret M; de Barbeyrac B;
    Lancet Infect Dis; 2022 Aug; 22(8):1221-1230. PubMed ID: 35550262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.
    Laurent C; Dembélé Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traoré I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fayé-Ketté H; Koné A; Diandé S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B;
    Lancet HIV; 2021 Jul; 8(7):e420-e428. PubMed ID: 34048794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
    Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.
    Bachmann LH; Barbee LA; Chan P; Reno H; Workowski KA; Hoover K; Mermin J; Mena L
    MMWR Recomm Rep; 2024 Jun; 73(2):1-8. PubMed ID: 38833414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.
    Hovaguimian F; Kouyos RD; Kusejko K; Schmidt AJ; Tarr PE; Bernasconi E; Braun DL; Calmy A; Notter J; Stoeckle M; Surial B; Christinet V; Darling KEA; Depmeier C; Läuchli S; Reinacher M; Rasi M; Nicca D; Bruggmann P; Haerry D; Bize R; Low N; Vock F; El Amari EB; Böni J; Bosshard PP; Fehr JS; Hampel B;
    HIV Med; 2024 Jan; 25(1):117-128. PubMed ID: 37771207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis.
    Zeggagh J; Bauer R; Delaugerre C; Carette D; Fressard L; Charreau I; Chidiac C; Pialoux G; Tremblay C; Cua E; Robineau O; Raffi F; Capitant C; Spire B; Meyer L; Molina JM;
    AIDS; 2022 Jul; 36(8):1129-1134. PubMed ID: 35142708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
    Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
    BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.